img

Global Neisseria meningitidis Infections Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neisseria meningitidis Infections Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Neisseria meningitidis Infections Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neisseria meningitidis Infections Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Neisseria meningitidis Infections Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Neisseria meningitidis Infections Drug key manufacturers include Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, China National Pharmaceutical Group Corp, GlaxoSmithKline Plc, Griffith University, ImmunoBiology Ltd, JN-International Medical Corp, MGB Biopharma Ltd and Panacea Biotec Ltd, etc. Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, China National Pharmaceutical Group Corp are top 3 players and held % sales share in total in 2022.
Neisseria meningitidis Infections Drug can be divided into MGBBP-3, NCL-195, TP-10 and Others, etc. MGBBP-3 is the mainstream product in the market, accounting for % sales share globally in 2022.
Neisseria meningitidis Infections Drug is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Neisseria meningitidis Infections Drug industry development. In 2022, global % sales of Neisseria meningitidis Infections Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neisseria meningitidis Infections Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
Segment by Type
MGBBP-3
NCL-195
TP-10
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neisseria meningitidis Infections Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Neisseria meningitidis Infections Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Neisseria meningitidis Infections Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Neisseria meningitidis Infections Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Neisseria meningitidis Infections Drug introduction, etc. Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Neisseria meningitidis Infections Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Neisseria meningitidis Infections Drug Market Overview
1.1 Neisseria meningitidis Infections Drug Product Overview
1.2 Neisseria meningitidis Infections Drug Market Segment by Type
1.2.1 MGBBP-3
1.2.2 NCL-195
1.2.3 TP-10
1.2.4 Others
1.3 Global Neisseria meningitidis Infections Drug Market Size by Type
1.3.1 Global Neisseria meningitidis Infections Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Neisseria meningitidis Infections Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Neisseria meningitidis Infections Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Neisseria meningitidis Infections Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Neisseria meningitidis Infections Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Neisseria meningitidis Infections Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Neisseria meningitidis Infections Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Neisseria meningitidis Infections Drug Sales Breakdown by Type (2018-2024)
2 Global Neisseria meningitidis Infections Drug Market Competition by Company
2.1 Global Top Players by Neisseria meningitidis Infections Drug Sales (2018-2024)
2.2 Global Top Players by Neisseria meningitidis Infections Drug Revenue (2018-2024)
2.3 Global Top Players by Neisseria meningitidis Infections Drug Price (2018-2024)
2.4 Global Top Manufacturers Neisseria meningitidis Infections Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neisseria meningitidis Infections Drug Market Competitive Situation and Trends
2.5.1 Neisseria meningitidis Infections Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Neisseria meningitidis Infections Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neisseria meningitidis Infections Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Neisseria meningitidis Infections Drug Market
2.8 Key Manufacturers Neisseria meningitidis Infections Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Neisseria meningitidis Infections Drug Status and Outlook by Region
3.1 Global Neisseria meningitidis Infections Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Neisseria meningitidis Infections Drug Historic Market Size by Region
3.2.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Neisseria meningitidis Infections Drug Sales in Value by Region (2018-2024)
3.2.3 Global Neisseria meningitidis Infections Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Neisseria meningitidis Infections Drug Forecasted Market Size by Region
3.3.1 Global Neisseria meningitidis Infections Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Neisseria meningitidis Infections Drug Sales in Value by Region (2024-2034)
3.3.3 Global Neisseria meningitidis Infections Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Neisseria meningitidis Infections Drug by Application
4.1 Neisseria meningitidis Infections Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Neisseria meningitidis Infections Drug Market Size by Application
4.2.1 Global Neisseria meningitidis Infections Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Neisseria meningitidis Infections Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Neisseria meningitidis Infections Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Neisseria meningitidis Infections Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Neisseria meningitidis Infections Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Neisseria meningitidis Infections Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Neisseria meningitidis Infections Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Neisseria meningitidis Infections Drug Sales Breakdown by Application (2018-2024)
5 North America Neisseria meningitidis Infections Drug by Country
5.1 North America Neisseria meningitidis Infections Drug Historic Market Size by Country
5.1.1 North America Neisseria meningitidis Infections Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Neisseria meningitidis Infections Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Neisseria meningitidis Infections Drug Sales in Value by Country (2018-2024)
5.2 North America Neisseria meningitidis Infections Drug Forecasted Market Size by Country
5.2.1 North America Neisseria meningitidis Infections Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Neisseria meningitidis Infections Drug Sales in Value by Country (2024-2034)
6 Europe Neisseria meningitidis Infections Drug by Country
6.1 Europe Neisseria meningitidis Infections Drug Historic Market Size by Country
6.1.1 Europe Neisseria meningitidis Infections Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Neisseria meningitidis Infections Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Neisseria meningitidis Infections Drug Sales in Value by Country (2018-2024)
6.2 Europe Neisseria meningitidis Infections Drug Forecasted Market Size by Country
6.2.1 Europe Neisseria meningitidis Infections Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Neisseria meningitidis Infections Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Neisseria meningitidis Infections Drug by Region
7.1 Asia-Pacific Neisseria meningitidis Infections Drug Historic Market Size by Region
7.1.1 Asia-Pacific Neisseria meningitidis Infections Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Neisseria meningitidis Infections Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Neisseria meningitidis Infections Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Neisseria meningitidis Infections Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Neisseria meningitidis Infections Drug Sales in Value by Region (2024-2034)
8 Latin America Neisseria meningitidis Infections Drug by Country
8.1 Latin America Neisseria meningitidis Infections Drug Historic Market Size by Country
8.1.1 Latin America Neisseria meningitidis Infections Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Neisseria meningitidis Infections Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Neisseria meningitidis Infections Drug Sales in Value by Country (2018-2024)
8.2 Latin America Neisseria meningitidis Infections Drug Forecasted Market Size by Country
8.2.1 Latin America Neisseria meningitidis Infections Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Neisseria meningitidis Infections Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Neisseria meningitidis Infections Drug by Country
9.1 Middle East and Africa Neisseria meningitidis Infections Drug Historic Market Size by Country
9.1.1 Middle East and Africa Neisseria meningitidis Infections Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Neisseria meningitidis Infections Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Neisseria meningitidis Infections Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Neisseria meningitidis Infections Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Neisseria meningitidis Infections Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Neisseria meningitidis Infections Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Beijing Minhai Biotechnology Co Ltd
10.1.1 Beijing Minhai Biotechnology Co Ltd Company Information
10.1.2 Beijing Minhai Biotechnology Co Ltd Introduction and Business Overview
10.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Products Offered
10.1.5 Beijing Minhai Biotechnology Co Ltd Recent Development
10.2 Biological E Ltd
10.2.1 Biological E Ltd Company Information
10.2.2 Biological E Ltd Introduction and Business Overview
10.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Biological E Ltd Neisseria meningitidis Infections Drug Products Offered
10.2.5 Biological E Ltd Recent Development
10.3 China National Pharmaceutical Group Corp
10.3.1 China National Pharmaceutical Group Corp Company Information
10.3.2 China National Pharmaceutical Group Corp Introduction and Business Overview
10.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Products Offered
10.3.5 China National Pharmaceutical Group Corp Recent Development
10.4 GlaxoSmithKline Plc
10.4.1 GlaxoSmithKline Plc Company Information
10.4.2 GlaxoSmithKline Plc Introduction and Business Overview
10.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Products Offered
10.4.5 GlaxoSmithKline Plc Recent Development
10.5 Griffith University
10.5.1 Griffith University Company Information
10.5.2 Griffith University Introduction and Business Overview
10.5.3 Griffith University Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Griffith University Neisseria meningitidis Infections Drug Products Offered
10.5.5 Griffith University Recent Development
10.6 ImmunoBiology Ltd
10.6.1 ImmunoBiology Ltd Company Information
10.6.2 ImmunoBiology Ltd Introduction and Business Overview
10.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Products Offered
10.6.5 ImmunoBiology Ltd Recent Development
10.7 JN-International Medical Corp
10.7.1 JN-International Medical Corp Company Information
10.7.2 JN-International Medical Corp Introduction and Business Overview
10.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 JN-International Medical Corp Neisseria meningitidis Infections Drug Products Offered
10.7.5 JN-International Medical Corp Recent Development
10.8 MGB Biopharma Ltd
10.8.1 MGB Biopharma Ltd Company Information
10.8.2 MGB Biopharma Ltd Introduction and Business Overview
10.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Products Offered
10.8.5 MGB Biopharma Ltd Recent Development
10.9 Panacea Biotec Ltd
10.9.1 Panacea Biotec Ltd Company Information
10.9.2 Panacea Biotec Ltd Introduction and Business Overview
10.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Products Offered
10.9.5 Panacea Biotec Ltd Recent Development
10.10 Pfizer Inc
10.10.1 Pfizer Inc Company Information
10.10.2 Pfizer Inc Introduction and Business Overview
10.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Pfizer Inc Neisseria meningitidis Infections Drug Products Offered
10.10.5 Pfizer Inc Recent Development
10.11 Sanofi Pasteur SA
10.11.1 Sanofi Pasteur SA Company Information
10.11.2 Sanofi Pasteur SA Introduction and Business Overview
10.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Products Offered
10.11.5 Sanofi Pasteur SA Recent Development
10.12 Serum Institute of India Ltd
10.12.1 Serum Institute of India Ltd Company Information
10.12.2 Serum Institute of India Ltd Introduction and Business Overview
10.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Products Offered
10.12.5 Serum Institute of India Ltd Recent Development
10.13 Wellstat Vaccines LLC
10.13.1 Wellstat Vaccines LLC Company Information
10.13.2 Wellstat Vaccines LLC Introduction and Business Overview
10.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Products Offered
10.13.5 Wellstat Vaccines LLC Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Neisseria meningitidis Infections Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Neisseria meningitidis Infections Drug Industrial Chain Analysis
11.4 Neisseria meningitidis Infections Drug Market Dynamics
11.4.1 Neisseria meningitidis Infections Drug Industry Trends
11.4.2 Neisseria meningitidis Infections Drug Market Drivers
11.4.3 Neisseria meningitidis Infections Drug Market Challenges
11.4.4 Neisseria meningitidis Infections Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Neisseria meningitidis Infections Drug Distributors
12.3 Neisseria meningitidis Infections Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of MGBBP-3
Table 2. Major Company of NCL-195
Table 3. Major Company of TP-10
Table 4. Major Company of Others
Table 5. Global Neisseria meningitidis Infections Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Neisseria meningitidis Infections Drug Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Neisseria meningitidis Infections Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Neisseria meningitidis Infections Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Neisseria meningitidis Infections Drug Market Share in Value by Type (2018-2024)
Table 10. Global Neisseria meningitidis Infections Drug Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Neisseria meningitidis Infections Drug Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Neisseria meningitidis Infections Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Neisseria meningitidis Infections Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Neisseria meningitidis Infections Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Neisseria meningitidis Infections Drug Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Neisseria meningitidis Infections Drug Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Neisseria meningitidis Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Neisseria meningitidis Infections Drug Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Neisseria meningitidis Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Neisseria meningitidis Infections Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Neisseria meningitidis Infections Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Neisseria meningitidis Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Neisseria meningitidis Infections Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Neisseria meningitidis Infections Drug Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Neisseria meningitidis Infections Drug Sales Share by Company (2018-2024)
Table 28. Global Neisseria meningitidis Infections Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Neisseria meningitidis Infections Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Neisseria meningitidis Infections Drug Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Neisseria meningitidis Infections Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Neisseria meningitidis Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neisseria meningitidis Infections Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Neisseria meningitidis Infections Drug Market
Table 35. Key Manufacturers Neisseria meningitidis Infections Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Neisseria meningitidis Infections Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Neisseria meningitidis Infections Drug Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Neisseria meningitidis Infections Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Neisseria meningitidis Infections Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Neisseria meningitidis Infections Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Neisseria meningitidis Infections Drug Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Neisseria meningitidis Infections Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Neisseria meningitidis Infections Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Neisseria meningitidis Infections Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Neisseria meningitidis Infections Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Neisseria meningitidis Infections Drug Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Neisseria meningitidis Infections Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Neisseria meningitidis Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Neisseria meningitidis Infections Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Neisseria meningitidis Infections Drug Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Neisseria meningitidis Infections Drug Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Neisseria meningitidis Infections Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Neisseria meningitidis Infections Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Neisseria meningitidis Infections Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Neisseria meningitidis Infections Drug Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Neisseria meningitidis Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 60. North America Neisseria meningitidis Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Neisseria meningitidis Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Neisseria meningitidis Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Neisseria meningitidis Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Neisseria meningitidis Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Neisseria meningitidis Infections Drug Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Neisseria meningitidis Infections Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Neisseria meningitidis Infections Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Neisseria meningitidis Infections Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Neisseria meningitidis Infections Drug Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Neisseria meningitidis Infections Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Neisseria meningitidis Infections Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Neisseria meningitidis Infections Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Neisseria meningitidis Infections Drug Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Neisseria meningitidis Infections Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Neisseria meningitidis Infections Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Neisseria meningitidis Infections Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Neisseria meningitidis Infections Drug Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Neisseria meningitidis Infections Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Neisseria meningitidis Infections Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Neisseria meningitidis Infections Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Neisseria meningitidis Infections Drug Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Neisseria meningitidis Infections Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Neisseria meningitidis Infections Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Neisseria meningitidis Infections Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Neisseria meningitidis Infections Drug Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Neisseria meningitidis Infections Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Neisseria meningitidis Infections Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Neisseria meningitidis Infections Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Beijing Minhai Biotechnology Co Ltd Company Information
Table 110. Beijing Minhai Biotechnology Co Ltd Introduction and Business Overview
Table 111. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product
Table 113. Beijing Minhai Biotechnology Co Ltd Recent Development
Table 114. Biological E Ltd Company Information
Table 115. Biological E Ltd Introduction and Business Overview
Table 116. Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Biological E Ltd Neisseria meningitidis Infections Drug Product
Table 118. Biological E Ltd Recent Development
Table 119. China National Pharmaceutical Group Corp Company Information
Table 120. China National Pharmaceutical Group Corp Introduction and Business Overview
Table 121. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product
Table 123. China National Pharmaceutical Group Corp Recent Development
Table 124. GlaxoSmithKline Plc Company Information
Table 125. GlaxoSmithKline Plc Introduction and Business Overview
Table 126. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product
Table 128. GlaxoSmithKline Plc Recent Development
Table 129. Griffith University Company Information
Table 130. Griffith University Introduction and Business Overview
Table 131. Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Griffith University Neisseria meningitidis Infections Drug Product
Table 133. Griffith University Recent Development
Table 134. ImmunoBiology Ltd Company Information
Table 135. ImmunoBiology Ltd Introduction and Business Overview
Table 136. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product
Table 138. ImmunoBiology Ltd Recent Development
Table 139. JN-International Medical Corp Company Information
Table 140. JN-International Medical Corp Introduction and Business Overview
Table 141. JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. JN-International Medical Corp Neisseria meningitidis Infections Drug Product
Table 143. JN-International Medical Corp Recent Development
Table 144. MGB Biopharma Ltd Company Information
Table 145. MGB Biopharma Ltd Introduction and Business Overview
Table 146. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product
Table 148. MGB Biopharma Ltd Recent Development
Table 149. Panacea Biotec Ltd Company Information
Table 150. Panacea Biotec Ltd Introduction and Business Overview
Table 151. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product
Table 153. Panacea Biotec Ltd Recent Development
Table 154. Pfizer Inc Company Information
Table 155. Pfizer Inc Introduction and Business Overview
Table 156. Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 157. Pfizer Inc Neisseria meningitidis Infections Drug Product
Table 158. Pfizer Inc Recent Development
Table 159. Sanofi Pasteur SA Company Information
Table 160. Sanofi Pasteur SA Introduction and Business Overview
Table 161. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 162. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product
Table 163. Sanofi Pasteur SA Recent Development
Table 164. Serum Institute of India Ltd Company Information
Table 165. Serum Institute of India Ltd Introduction and Business Overview
Table 166. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 167. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product
Table 168. Serum Institute of India Ltd Recent Development
Table 169. Wellstat Vaccines LLC Company Information
Table 170. Wellstat Vaccines LLC Introduction and Business Overview
Table 171. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 172. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product
Table 173. Wellstat Vaccines LLC Recent Development
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Neisseria meningitidis Infections Drug Market Trends
Table 177. Neisseria meningitidis Infections Drug Market Drivers
Table 178. Neisseria meningitidis Infections Drug Market Challenges
Table 179. Neisseria meningitidis Infections Drug Market Restraints
Table 180. Neisseria meningitidis Infections Drug Distributors List
Table 181. Neisseria meningitidis Infections Drug Downstream Customers
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Neisseria meningitidis Infections Drug Product Picture
Figure 2. Global Neisseria meningitidis Infections Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Neisseria meningitidis Infections Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Neisseria meningitidis Infections Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of MGBBP-3
Figure 6. Global MGBBP-3 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of NCL-195
Figure 8. Global NCL-195 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of TP-10
Figure 10. Global TP-10 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Neisseria meningitidis Infections Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Neisseria meningitidis Infections Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Neisseria meningitidis Infections Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Neisseria meningitidis Infections Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Neisseria meningitidis Infections Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Neisseria meningitidis Infections Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Neisseria meningitidis Infections Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Neisseria meningitidis Infections Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Neisseria meningitidis Infections Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Neisseria meningitidis Infections Drug Revenue in 2022
Figure 27. Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Global Neisseria meningitidis Infections Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Neisseria meningitidis Infections Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Neisseria meningitidis Infections Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Neisseria meningitidis Infections Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Neisseria meningitidis Infections Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Neisseria meningitidis Infections Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Neisseria meningitidis Infections Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Neisseria meningitidis Infections Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Neisseria meningitidis Infections Drug Manufacturing Cost Structure
Figure 47. Neisseria meningitidis Infections Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries